|
|
|
 |
|
|
 |
|
|
| |
 |
| |
 |
| |
| |
 |
| Corixa Corporation (CRXA) |
OBP IV |
(Merged with and into a wholly owned subsidiary of SmithKline, Beecham Corporation)
Seattle, WA
Corixa Corporation develops therapeutic products for the treatment and prevention of cancer, autoimmune and infectious diseases. BEXXAR®, the Company's most advanced product candidate, is an investigational radioimmunotherapy that combines the targeting ability of a monoclonal antibody and the therapeutic potential of radiation, with patient-specific dosing.
|
|
| |
|
|
|
|
|
